Hepatocellular carcinoma (HCC) is a major global health issue, with significant morbidity and mortality rates. As the sixth most common cancer and the third leading cause of cancer-related deaths, HCC ...
SLU Hospital is the first in Missouri to offer Cytalux, a 'glowing tumor' injection that helps surgeons see lung cancer ...
Fluorescence-guided surgery has become a new standard of care for certain types of tumor resection. It involves a patient ingesting a substance prior to surgery that will metabolize and fluoresce ...
As many as 40% of lumpectomies leave positive margins that necessitate a second surgery, but a novel fluorescent imaging agent used along with a direct visualization system may improve complete ...
Successful surgery for head and neck squamous cell carcinoma (HNSCC) relies upon complete tumor removal and safe preservation of the fragile nerves in the vicinity. Both are challenging. Fluorescence ...
A research group from Nagoya University has successfully developed a surgical training model using konjac, a processed jelly made from the bulb of the konjac plant. Konjac is commonly used as an ...
NIVACOR: Phase II study of nivolumab in combination with FOLFOXIRI/bevacizumab in first-line chemotherapy for advanced colorectal cancer RASm/BRAFm patients. TRACC: Tracking mutations in cell-free DNA ...
MADISON, Wis.--(BUSINESS WIRE)--OnLume Inc., a Madison, Wisconsin-based medical imaging company with unique technology for improving surgical precision in the operating room, has announced the start ...
Getinge AB is acquiring 100% of the equity in fluorescence imaging company Fluoptics SAS, a company using the technology as an aid to surgery. Getinge will, through its subsidiary Getinge Infection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results